Pfizer Inc. news

   Watch this stock
Showing stories 11 - 20 of about 174   

Articles published

PFE 34.28
price chart
4 Notable Runners: Microsoft Corporation (NASDAQ:MSFT), Pfizer Inc. (NYSE ...
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); ...
Active News Buzz: Pfizer Inc. (NYSE:PFE), Boston Scientific Corporation (NYSE ...
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); ...
Most Active Stocks To Watch List: AT&T, Inc. (NYSE:T), Pfizer Inc. (NYSE:PFE ...
Pfizer Inc. (NYSE: PFE) saw its short interest decrease to 88.8 million shares from the previous 109.6 million. Since February, short interest has been incredibly elevated, and the current reading is just backing off of this.
Pfizer Would Benefit From Glaxo Takeover, Deutsche Bank Says
Pfizer Inc. would benefit from a takeover of U.K. rival GlaxoSmithKline Plc, a Deutsche Bank AG analyst wrote in a note to clients titled “Introducing PfizerKline.
Earnings Buzz: Pfizer Inc (PFE), Merck & Co Inc (MRK), Bristol-Myers Squibb Co ...
Pfizer Inc. (NYSE:PFE) shares edged up 0.5 percent Tuesday, despite cutting its full-year 2015 earnings forecast due to a stronger U.S.
Whisper Numbers: Pfizer Inc. (PFE), Merck & Co., Inc. (MRK), And Bristol ...  Bidness ETC
Pfizer, Merck and Bristol-Myers Squibb Report Solid Results  Wall Street Journal
23andMe Launches the Lupus Research Study in Collaboration with Pfizer Inc.
MOUNTAIN VIEW, Calif., May 5, 2015 /PRNewswire/ -- 23andMe, Inc., the leading personal genetics company, today announced the launch of the Lupus Research Study in collaboration with Pfizer Inc. The companies aim to enroll 5,000 individuals with ...
23andMe, Pfizer jointly launch Lupus Research Study  News-Medical.net
23andMe launches the lupus research study in collaboration with Pfizer  Medical Xpress
Pfizer Inc. (NYSE:PFE) Strengthening Itself and Gearing For Top Position
Pfizer Inc.(NYSE:PFE) is famous for its strategy of making acquisitions to get their hands on a particular product and forming alliances with other major players.
Could This Dark Horse Be Pfizer Inc.'s Next Major Acquisition?
Given that buyouts can quickly change the complexion of a company, as well as its forward-looking prospects, I think it's definitely worthwhile to consider possible buyout scenarios.
Pfizer is unnamed bidder for Swedish rare disease firm Orphan Biovitrum  domain-B
Exclusive: Pfizer is mystery bidder for rare disease drugmaker Sobi - sources
TA) acquisition of Auspex Pharmaceuticals for $3.5 billion in March, Shire Plc's (SHP.L) acquisition of NPS Pharmaceuticals for $5.2 billion in January and BioMarin Pharmaceutical Inc's (BMRN.O) acquisition of Prosensa Holding NV for $840 million last ...
Earnings Buzz: Apple Inc (AAPL), Twitter Inc (TWTR), LinkedIn Corp (LNKD ...
As Apple Inc. releases quarterly results after the closing bell on Monday, the earnings season gets into full swing this week. Social media company Twitter Inc. and drugmaker Pfizer Inc. report results Tuesday, followed by professional networking site ...